Mira Pharmaceuticals (MIRA) Other financing activities (2022 - 2025)

Mira Pharmaceuticals has disclosed Other financing activities across 3 years of filings, most recently posting $158421.0 for Q4 2025.

• Other financing activities for Q4 2025 came in at $158421.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $270990.0 (up 242.86% YoY), and the FY2025 annual result was $292470.0, up 767.53% from the prior year.
• Other financing activities came in at $158421.0 for Q4 2025 at Mira Pharmaceuticals, up from $112569.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $163684.0 in Q2 2023 to a low of -$353372.0 in Q3 2023.
• The 3-year median for Other financing activities is $79415.0 (2023), against an average of $22068.7.